ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,528 | -99.9% | 117,000 | 0.0% | 1.79% | +12.0% |
| Q3 2022 | $2,265,000 | +0.9% | 117,000 | +3.5% | 1.60% | -2.3% |
| Q2 2022 | $2,244,000 | -33.4% | 113,000 | 0.0% | 1.63% | -32.8% |
| Q1 2022 | $3,371,000 | +28.1% | 113,000 | 0.0% | 2.43% | +43.0% |
| Q4 2021 | $2,632,000 | -25.4% | 113,000 | 0.0% | 1.70% | -29.3% |
| Q3 2021 | $3,526,000 | -9.7% | 113,000 | +1.8% | 2.40% | +2.7% |
| Q2 2021 | $3,905,000 | -0.2% | 111,000 | 0.0% | 2.34% | +0.6% |
| Q1 2021 | $3,913,000 | +13.4% | 111,000 | +20.7% | 2.32% | +16.9% |
| Q4 2020 | $3,451,000 | -10.8% | 92,000 | -20.7% | 1.99% | +53.8% |
| Q3 2020 | $3,870,000 | +204.2% | 116,000 | +141.7% | 1.29% | +68.1% |
| Q2 2020 | $1,272,000 | +61.8% | 48,000 | 0.0% | 0.77% | +10.3% |
| Q1 2020 | $786,000 | -35.6% | 48,000 | 0.0% | 0.70% | -21.4% |
| Q4 2019 | $1,220,000 | +60.5% | 48,000 | +26.3% | 0.89% | +75.3% |
| Q3 2019 | $760,000 | -38.0% | 38,000 | 0.0% | 0.51% | -32.1% |
| Q2 2019 | $1,225,000 | +0.1% | 38,000 | 0.0% | 0.74% | -2.9% |
| Q1 2019 | $1,224,000 | +31.3% | 38,000 | 0.0% | 0.77% | -13.0% |
| Q4 2018 | $932,000 | -25.6% | 38,000 | 0.0% | 0.88% | +9.2% |
| Q3 2018 | $1,252,000 | -7.2% | 38,000 | 0.0% | 0.81% | -11.9% |
| Q2 2018 | $1,349,000 | +72.5% | 38,000 | +58.3% | 0.92% | +78.1% |
| Q1 2018 | $782,000 | – | 24,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |